packageEnasidenib

enasidenib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Enasidenib is an anticancer medicine, an IDH inhibitor, used to treat acute myeloid leukemia. It is an approved drug, though it has no European Union authorisation recorded, and remains investigational for some uses.

Summary written by glm-5.3-flash from Wikidata Q27077182 and the WHO ATC classification; not checked by a person.

name:enasidenib
ATC codes:L01XM01
DrugBank:DB13874
PubChem CID:89683805
ChEBI:145374
Wikidata:Q27077182
formula:C19H17F6N7O
molar mass:473.381 g/mol (PubChem CID 89683805)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown